Drug Delivery Devices Market Research Report Information By Route of Administration (Oral, Ocular, Inhalation, Nasal, Injectable, Topical, and Others), By Application (Cardiovascular, Diabetes, Cancer, Infectious Diseases, and Others), By End User (Hospitals, Ambulatory Services, and Home Healthcare), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Modality

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION

6.1. Overview

6.2. Oral

6.3. Ocular

6.4. Inhalation

6.5. Nasal

6.6. Injectable

6.7. Topical

6.8. Others

7. GLOBAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION

7.1. Overview

7.2. Cardiovascular

7.3. Diabetes

7.4. Cancer

7.5. Infectious Diseases

7.6. Others

8. GLOBAL DRUG DELIVERY DEVICES MARKET, BY END-USER

8.1. Overview

8.2. Hospitals

8.3. Ambulatory Services

8.4. Home Healthcare

9. GLOBAL DRUG DELIVERY DEVICES MARKET, BY REGION

9.1. Overview

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.3. Europe

9.3.1. Germany

9.3.2. France

9.3.3. U.K

9.3.4. Italy

9.3.5. Spain

9.3.6. Rest of Europe

9.4. Asia-Pacific

9.4.1. China

9.4.2. India

9.4.3. Japan

9.4.4. South Korea

9.4.5. Australia

9.4.6. Rest of Asia-Pacific

9.5. Rest of the World

9.5.1. Middle East

9.5.2. Africa

9.5.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Drug Delivery Devices Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Drug Delivery Devices Market,

10.7. Key developments and Growth Strategies

10.7.1. New Route of Administration Launch/Application Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES

11.1. Pfizer, Inc.

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Route of Administrations Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Hoffmann-La Roche Ltd

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Route of Administrations Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Johnson and Johnson Private Ltd

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Route of Administrations Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Novartis AG

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Route of Administrations Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Bayer AG

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Route of Administrations Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. BECTON

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Route of Administrations Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Dickinson and Company

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Route of Administrations Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Uniqure NV

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Route of Administrations Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL DRUG DELIVERY DEVICES MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL DRUG DELIVERY DEVICES MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 GLOBAL DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 7 NORTH AMERICA DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 8 NORTH AMERICA DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 9 NORTH AMERICA DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 10 U.S. DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 11 U.S. DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 12 U.S. DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 13 CANADA DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 14 CANADA DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 15 CANADA DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 16 EUROPE DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 17 EUROPE DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 18 EUROPE DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 19 EUROPE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 20 GERMANY DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 21 GERMANY DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 22 GERMANY DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 23 FRANCE DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 24 FRANCE DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 25 FRANCE DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 26 ITALY DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 27 ITALY DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 28 ITALY DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 29 SPAIN DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 30 SPAIN DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 31 SPAIN DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 32 U.K DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 33 U.K DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 34 U.K DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 35 REST OF EUROPE DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 36 REST OF EUROPE DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 37 REST OF EUROPE DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 38 ASIA PACIFIC DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 39 ASIA PACIFIC DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 40 ASIA PACIFIC DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 41 ASIA PACIFIC DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 42 JAPAN DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 43 JAPAN DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 44 JAPAN DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 45 CHINA DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 46 CHINA DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 47 CHINA DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 48 INDIA DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 49 INDIA DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 50 INDIA DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 51 AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 52 AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 53 AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 54 SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 55 SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 56 SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 57 REST OF ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 58 REST OF ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 59 REST OF ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 60 REST OF WORLD DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 61 REST OF WORLD DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 62 REST OF WORLD DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 63 REST OF WORLD DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 64 MIDDLE EAST DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 65 MIDDLE EAST DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 66 MIDDLE EAST DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 67 AFRICA DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 68 AFRICA DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 69 AFRICA DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 70 LATIN AMERICA DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 71 LATIN AMERICA DRUG DELIVERY DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 72 LATIN AMERICA DRUG DELIVERY DEVICES MARKET, BY END-USER, 2018-2032 (USD BILLION) 

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL DRUG DELIVERY DEVICES MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL DRUG DELIVERY DEVICES MARKET

FIGURE 4 GLOBAL DRUG DELIVERY DEVICES MARKET, SHARE (%), BY ROUTE OF ADMINISTRATION, 2022

FIGURE 5 GLOBAL DRUG DELIVERY DEVICES MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 6 GLOBAL DRUG DELIVERY DEVICES MARKET, SHARE (%), BY END-USER, 2022

FIGURE 7 GLOBAL DRUG DELIVERY DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 NORTH AMERICA: DRUG DELIVERY DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 EUROPE: DRUG DELIVERY DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 ASIA-PACIFIC: DRUG DELIVERY DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 REST OF THE WORLD: DRUG DELIVERY DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 GLOBAL DRUG DELIVERY DEVICES MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 13 PFIZER, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 PFIZER, INC.: SWOT ANALYSIS

FIGURE 15 HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS

FIGURE 17 JOHNSON AND JOHNSON PRIVATE LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 JOHNSON AND JOHNSON PRIVATE LTD: SWOT ANALYSIS

FIGURE 19 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 NOVARTIS AG: SWOT ANALYSIS

FIGURE 21 BAYER AG.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 BAYER AG.: SWOT ANALYSIS

FIGURE 23 BECTON: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 BECTON: SWOT ANALYSIS

FIGURE 25 DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 DICKINSON AND COMPANY: SWOT ANALYSIS

FIGURE 27 UNIQURE NV: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 UNIQURE NV: SWOT ANALYSIS